Randomized, Double-Blind, Placebo-Controlled Phase IIb Trial of Inhaled N,N-Dimethyltryptamine (DMT) for Major Depressive Disorder

Phase: PHASE2 | Sponsor: Universidade Federal do Rio Grande do Norte | Compound: DMT

Status

recruiting

Institution

Universidade Federal do Rio Grande do Norte

Start date

2026-08-01

End date

2027-08-01

Registry ID

NCT07562191

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.